Gastric carcinoma is the fourth most common cause of cancer death worldwide but its molecular biology is poorly understood. We catalogued the genes expressed in two gastric adenocarcinomas and normal stomach, using serial analysis of gene expression (SAGE), and compared the profiles on-line with other glandular epithelia. Candidates were validated by Northern blotting and immunohistochemistry. A total of 29 480 transcripts, derived from 10 866 genes, were identified. In all, 1% of the genes were differentially expressed (Xfivefold difference plus P-value p0.01) between cancers and normal stomach. The most abundant transcripts included ribosomal and mitochondrial proteins, of which most were upregulated in the tumours, as were other widely expressed genes including transcription factors, signalling molecules (serine/threonine protein kinases), thymosin beta 10 and collagenase I. Transcripts abundant in normal stomach were functionally important, including gastrin, immunoglobulin alpha, lysozyme, MUC5, pS2 and pepsinogens, which were among 55 gastric-specific genes. Many transcripts were minimally characterized or new, some cancer-associated genes reflected their intestinal morphology, and some normal gastric genes had previously been considered as pancreatic carcinoma markers. The gastric carcinoma profiles resembled other tumours', supporting the existence of common cancer-associated targets. These data provide a catalogue from which to develop markers for better diagnosis and therapy of gastric carcinoma.
Introduction
Gastric carcinoma is a common tumour with a high mortality (Fuchs and Mayer, 1995; Blok et al., 1997) . Worldwide, it is the fourth most common cause of cancer death (Parkin, 2001) . It ranks fifth in Scotland, where the overall 5-year survival for gastric carcinoma is only around 12%, which compares poorly with 44% for colonic carcinoma (Harris et al., 1998) . The reason is that most patients with gastric carcinoma in the Western world develop symptoms and are diagnosed when disease is locally advanced, often with metastases (Roukos, 2000) . Curative surgery is then no longer possible, and effective adjuvant therapies are not yet well-established. Much better survival figures of over 80% can be achieved, however, when the tumour is identified and treated at an earlier clinical stage (Roukos, 2000) .
Over 90% of cancers in the stomach are carcinomas (specifically, adenocarcinomas), but these are heterogeneous (Fuchs and Mayer, 1995; Blok et al., 1997) . Many classifications exist: the two most common subdivide tumours by anatomical location (Owen, 1986) , into distal and proximal, and by histopathology, into intestinal and diffuse cancers (Laure´n, 1965) . These tumour subtypes differ in their epidemiology and aetiology, as well as in their molecular biology. Most of the classic cancer-associated molecular alterations have been found in gastric carcinomas (Hanahan and Weinberg, 2000) , and some, such as loss of functional p53 and telomerase activation, are common to all tumour subtypes (Blok et al., 1997; Chan et al., 1999) . Downregulation of cell adhesion molecules, such as cadherins, however, is associated mainly with diffuse cancers; E-cadherin mutations were recently the first germline changes to be identified as predisposing to (diffuse) gastric carcinoma (Guilford et al., 1998) . Conversely, such abnormalities are uncommon in tumours of intestinal type, which in molecular terms resemble colonic carcinomas so frequently containing adenomatous polyposis coli (APC) mutations (Chan et al., 1999) .
Such classical molecular studies of gastric carcinoma have been extremely fruitful, but have of necessity focused on small numbers of genes. Changes in the global pattern of gene transcription may be equally significant, and technological advances now permit their investigation (Carulli et al., 1998) . Gastric carcinoma has been studied using differential display, Clontech cDNA membrane arrays and cDNA microarrays (Ebert et al., 2000; Jung et al., 2000; Yoshikawa et al., 2000; ElRifai et al., 2001; Wang et al., 2001; Hippo et al., 2002; Mori et al., 2002) . However, we chose to use serial analysis of gene expression (SAGE), which produces comprehensive, quantitative and reproducible gene expression profiles (Velculescu et al., 2000) .
SAGE is based on generating clones of concatenated (linked) short sequence tags derived from mRNA from the target tissue (Velculescu et al., 1995; Zhang et al., 1997) . Each tag is 9 or 10 bp long and represents a single mRNA transcript; each clone insert contains up to 40 tags joined together. Sequencing of multiple concatenates therefore efficiently describes the pattern and numbers of genes expressed. The mRNA transcript corresponding to the short SAGE tag is identified via genetic databases. As SAGE is labour-intensive and hence limited to small numbers of specimens, resulting candidate genes are usually validated in a larger sample set. SAGE has already been applied to the other common adenocarcinomas, of colon, pancreas, breast, ovary and prostate, and to squamous lung carcinoma and other cancers (Velculescu et al., 1995; Zhang et al., 1997; Hibi et al., 1998; Lal et al., 1999; Nacht et al., 1999; Velculescu et al., 1999; Hough et al., 2000; Waghray et al., 2001 ) but, to our knowledge, no SAGE data for gastric carcinoma have yet been published in the literature.
Since the most common subtype of gastric carcinoma is distal and intestinal (Fuchs and Mayer, 1995) , we have generated SAGE profiles of two such tumours, along with one sample of normal gastric antral (distal) mucosa. From the resulting catalogues of gene expression, we have highlighted abundant, differentially expressed and gastric-specific transcripts and have validated selected genes in a wider panel of normal and tumour gastrointestinal tissues.
Results

Generation of gastric SAGE tag libraries
SAGE libraries were created from two gastric adenocarcinomas, both of distal, intestinal subtype, and from normal gastric antral mucosa. After excluding inappropriate tags (resulting from duplicate ditags or linker sequences), we obtained a total of 29 480 tags, or transcripts, derived from 10 866 different genes (unique tags). The libraries from tumour 1, tumour 2 and normal stomach contained 10 222, 10 825 and 8433 tags, respectively (Table 1) . To permit direct comparison, each library was normalized to a total of 10 000 tags (at which level, a tag present 10 times has an abundance of 0.1%). The normalized, rather than absolute, tag counts are used henceforth. Table 1 presents a global analysis of the three SAGE libraries. The most common tag was CTCCCCCAA, which was found 781 times (7.8%) in normal stomach and represents immunoglobulin alpha (IgA). Only around seven genes were expressed at levels of 1% or over in each library. In contrast, the vast majority (97-98%) of transcripts, including the classical housekeeping genes, were present at levels in single figures (below 0.1%). The global figures for each library were similar.
Global analysis of gastric SAGE libraries
Global comparison of gastric carcinoma and normal SAGE libraries
Differential expression between libraries was defined as a difference in tag ratio of fivefold or more, combined with a P-value of 0.01 or less. When tags from the two tumours were pooled and compared with normal stomach, 106 tags were differentially expressed (0.97% of the total genes in the three libraries), of which 47 were higher in the tumours and 59 were higher in normal stomach. These genes are listed in Table 2 . When compared individually with normal stomach, 76 tags (1.09%) and 125 tags (1.53%) were differentially expressed in tumours 1 and 2, respectively, of which 85 tags were upregulated in either tumour. The two tumours themselves differed by 64 tags (0.75%). These results are in keeping with their histopathology: tumour 1 was better differentiated and of an earlier stage.
Global comparison of gastric libraries digitally with SAGE libraries from other glandular epithelial tissues and mesothelium
The normal gastric SAGE library was compared digitally with normal breast, colonic, ovarian, pancreatic and prostatic tissue and with normal mesothelium. In total, 55 genes (0.65% of the total genes in the normal The two tumour and the normal samples are represented by T1, T2 and N, respectively. The absolute tag counts are normalized to 10 000 total tags per sample to permit direct comparison. Genes expressed highly, differentially or (tissue-)specifically in the tumours are shaded in mid grey, whereas the equivalents in normal stomach are shaded in light grey. Genes which are highly or (tissue-)specifically expressed in both tumour and normal libraries but which are not differentially expressed are shaded in black. Differential expression between the tumours and normal stomach was defined as a difference of fivefold or more combined with a P-value of 0.01 or less. 'Pool' indicates that the genes were differentially expressed in a comparison using the pooled tumours. 'T either' indicates that the tag was differentially expressed only in an individual comparison between one or other tumour and normal gastric antrum. e Tissue-specific gene expression was defined as in note d gastric library) were specifically overexpressed in normal stomach. These genes are also listed in Table 2 . The pooled gastric adenocarcinomas were compared with SAGE tumour libraries of breast ductal carcinoma, ovarian serous adenocarcinoma, colonic, pancreatic and prostatic adenocarcinomas, and malignant mesothelioma of epithelial type. A total of 20 genes (0.23% of the total genes in the pooled gastric tumour libraries) were specifically overexpressed in gastric carcinoma. Eight gastric-specific genes were common to both tumour and normal comparisons. Of the 47 tags more highly expressed in the pooled tumours than in normal stomach, only five were also gastric-specific. In contrast, of the 59 genes more highly expressed in normal stomach compared with the pooled tumours, 33 were also gastric-specific. Table 2 contains the tags differentially expressed between the gastric carcinomas and normal stomach, plus the gastric-specific tags. The 20 most abundant tags in each library are also listed and included many ribosomal and mitochondrial proteins, of which many were more highly expressed in the tumours. Most other transcripts upregulated in the tumours are expressed in many cell types and will henceforth be termed 'widely expressed'. These included growth factors, signal transduction molecules, transcription factors, thymosins and genes involved in protein turnover and cellular invasion. Conversely, most cytoskeletal proteins were downregulated in the tumours.
Investigation of individual SAGE tags
Most genes that were more highly expressed in normal stomach than in gastric carcinoma play a role in normal gastric function (Owen, 1986) , and many were gastric-specific compared with other epithelial libraries. The SAGE profiles were thus self-validating. Such genes included the gut hormone gastrin, the antibacterial lysozyme, and gastric mucin (MUC5) and trefoil factors pS2 and spasmolytic polypeptide that protect glandular epithelia. Some genes were only recently characterized: lipocalin 2, prostate stem cell antigen (PSCA), and a new gene designated CA11. Others had not been reported in the stomach, such as aquaporin 5. Many differentially or specifically expressed tags corresponded only to uncharacterized cDNAs (expressed sequence tags or ESTs) or entirely lacked a match in the genetic databases.
A few genes, such as the intestinal trefoil factor, were upregulated in gastric carcinoma, but were not widely expressed; instead, their normal location was the intestine.
Northern blotting
To validate and expand the SAGE profiles, we studied selected transcripts in a wider panel of 19 gastrointestinal tumour and normal tissues and cell lines. Where the genes had been previously minimally characterized, Northern blotting for mRNA was used and broadly corroborated the SAGE profiles (Figure 1 ).
Gastrin was expressed highly and only in the normal gastric antrum. The new gene CA11 was expressed highly and only in normal stomach, in all areas. Prostate stem cell antigen (PSCA) was indeed present in normal gastric mucosa and in four of the eight gastric tumours. Lipocalin 2 (neutrophil gelatinase-associated lipocalin) was present in normal antrum and the two SAGE tumours, although its relative levels differed slightly from those expected.
As predicted, intestinal trefoil factor was identified in seven of the eight gastric tumours, and in normal colon and its adenocarcinoma. Of the widely expressed genes, thymosin beta 10 was indeed upregulated in the gastric and cell lines, but was also abundant in the tumour and normal oesophagus and colon. Id1 was highly expressed in the two SAGE tumours, as predicted, but was present at similar levels in normal stomach, and was in fact lower in the other gastric tumours and, perhaps unexpectedly, absent from the three cell lines. Prothymosin alpha tended to be more highly expressed in the tumours than in the normal samples but its relative levels in the SAGE samples were rather low. Overall, Northern blotting showed significant differences in expression levels between tumours, even of the same subtype.
Heat-shock protein 90 alpha (Hsp90a) was included because of a tag, ACGCAGGGA, which was abundant in the tumours but low in normal stomach. SAGEmap on-line suggested a match to the Unigene cluster of Hsp90a. However, by Northern blotting, Hsp90a was low and not differentially expressed ( Figure 1 ). In fact, one of the three gene sequences in this cluster was a chimaera composed partly of Hsp90a and partly of an unknown gene. The tag of interest corresponded only to the latter, which remains uncharacterized; in this instance, the problem with validation arose from the Unigene databases rather than the SAGE profiles.
Immunohistochemistry
Better characterized genes for which antibodies were available were validated by IHC, which provides localization and identifies the gene's protein product rather than its mRNA transcript. Nevertheless, IHC corroborated the SAGE profiles. Figure 2 shows the three SAGE samples stained for gastrin, lysozyme, pS2, spasmolytic polypeptide and MUC5. Table 3 lists the IHC results for the full gastrointestinal panel.
As predicted, lysozyme, pS2, MUC5 and spasmolytic polypeptide were highly expressed in normal gastric mucosa. Lysozyme, pS2 and MUC5 were present in all of the distal gastric carcinomas, of both histological subtypes, although their levels varied and were generally lower than in normal tissue. In the three SAGE samples, the relative IHC staining paralleled the mRNA profiles, with one exception: SAGE had predicted lysozyme to be absent from tumour 2, but although some areas were indeed negative by IHC (Figure 2 ), focal positive staining was present elsewhere.
Spasmolytic polypeptide, which was absent or very low in the SAGE tumours, was present in only two tumours in the wider panel, neither of distal, intestinal type. As predicted, gastrin was expressed only in normal antrum, in the G-cells (Figure 2 ). All samples contained keratin 8, as expected for simple glandular epithelia, except for normal oesophagus and oesophageal squamous carcinoma, which comprise stratified squamous epithelium. Overall, IHC staining in the tumours, but not in the normal mucosa, was heterogeneous, both within and between cancers, even those of the same subtype.
Discussion
These are the first global profiles of gene expression in gastric carcinoma and normal stomach created using SAGE. We have generated two libraries of gastric adenocarcinoma of distal, intestinal type, and one library of normal gastric antral mucosa. Numerous transcripts have been identified which are: highly expressed, differentially expressed between normal and tumour stomach, or gastric-specific by comparison with normal and tumour breast, colon, ovary, pancreas, prostate and mesothelium. Selected genes have been validated in a wider panel of 19 gastrointestinal tissues by Northern blotting and immunohistochemistry.
Our data are internally consistent: the validation studies corroborated the gastric SAGE profiles for 13 out of 15 transcripts. This correlation is at least as good as previous SAGE papers in which between 7 and 50% of differentially expressed tags were not corroborated (Zhang et al., 1997; Hibi et al., 1998; de Waard et al., 1999; Waghray et al., 2001) . Moreover, although mRNA abundance can be a poor indicator of protein levels (Pradet-Balade et al., 2001), we found that, for a given gene, the relative level of mRNA in different samples correlated well with the relative protein level as gauged by immunohistochemical staining (Figure 2 ). However, while gene expression in normal tissue from one site was uniform, it varied significantly within and between tumours, even of the same type, at both mRNA and protein levels (Figures 1 and 2 and Tables 2 and 3); such tumour heterogeneity is a well-recognized phenomenon (Zhang et al., 1997; Hibi et al., 1998; Lal et al., 1999; Perou et al., 2000) .
Each of our three SAGE gene expression libraries yielded around 10 000 tags, or transcripts, derived from an average of 4300 genes. These numbers are slightly smaller than those in other recent SAGE publications, with upwards of 20 000 tags (Zhang et al., 1997; Hibi et al., 1998; Nacht et al., 1999; Velculescu et al., 1999; Hough et al., 2000; Waghray et al., 2001) . However, the global distribution of genes in our gastric libraries is Figure 1 Northern blotting for selected genes identified by SAGE. RNA was isolated from 19 gastrointestinal tumour and normal tissues and cell lines, as indicated along the top row, of which further details are listed in Table 3 similar to these previous SAGE profiles, as are the underlying library creation statistics, with only around seven transcripts expressed at levels of 1% or more, and over 97% present at levels of 0.1% or less.
Only 1% of the transcripts were differentially expressed between the pooled gastric carcinoma libraries and normal stomach. This figure is similar to previous SAGE papers comparing other adenocarcinomas with their normal tissues (Zhang et al., 1997; Hibi et al., 1998; Nacht et al., 1999; Velculescu et al., 1999; Hough et al., 2000; Waghray et al., 2001) . When compared individually with normal stomach, the moderately differentiated gastric carcinoma yielded more differentially expressed tags (T2: 125 tags) than the well-differentiated tumour (T1: 76 tags), so the molecular pathology agrees with the morphology. The 99% of transcripts which were therefore expressed at similar levels in normal and tumour tissues would presumably be unlikely to make good diagnostic or therapeutic targets, unless of course the resulting protein differed in its abundance, stability or functional state.
In total, 55 gastric-specific genes (0.65%) emerged from the comparison of normal stomach with other normal glandular epithelia (breast, colon, ovary, pancreas and prostate) and mesothelium. In Velculescu et al's (1999) paper on the 'human transcriptome', estimates of the proportion of tissue-specific genes in normal samples varied from 0.09% (keratinocytes) to 1.76% (colon). Our figure is in keeping with this range.
Genes specifically overexpressed in gastric carcinoma compared with other adenocarcinomas and malignant mesothelioma were fewer in number: 20 (0.24%). Comparable data for tissue-specific genes in tumours are difficult to find. However, extrapolation from a study using Digital Differential Display, one of NCBI's data-mining tools, comparing adenocarcinomas of breast, colon, lung, ovary, pancreas and prostate, suggests that the number of tissue-specific genes in each tumour type is around 16 (Scheurle et al., 2000) , again consistent with our figure. That there were fewer tissue-specific genes in gastric carcinoma than in normal stomach is in keeping with the tumours reverting to a less specialized, that is, less differentiated state.
The most abundant transcripts in all three gastric SAGE libraries included ribosomal and mitochondrial genes, and these were generally upregulated in the tumours. This agrees with the previous global expression profiles and the comparisons of cancers and the corresponding normal tissues in general (Zhang et al., 1997; Hibi et al., 1998; de Waard et al., 1999; Velculescu et al., 1999; Perou et al., 2000) , and of gastric carcinoma and normal stomach in particular (Salesiotis et al., 1995; Ebert et Table 3 , but these photomicrographs depict representative areas from the two distal, intestinal tumours (T1 and T2) and normal stomach (antrum) (N) which were subjected to SAGE. The magnification is the same throughout. The number in the bottom left-hand corner is the normalized SAGE tag count for comparison. Spasm polypep indicates human spasmolytic polypeptide (TFF2) Most other transcripts upregulated in the tumours were 'widely expressed' and many had classical protooncogenic functions. Only five of the 47 tags upregulated in the pooled tumours were gastric-specific, compared with 33 of 59 tags more highly expressed in normal stomach, again in keeping with cellular dedifferentiation during malignant transformation. Of the transcripts further investigated, Id1 was expressed in the gastric carcinomas, and at lower levels in normal stomach. Id1 is a member of the ID (inhibitor of differentiation) family of proteins, which inhibit basic helix-loop-helix transcription factors; high Id1 levels correlate with a more aggressive phenotype in breast carcinoma (Norton, 2000) . Id1's upregulation in the SAGE tumour samples is thus predictable, but the similar levels in normal stomach, lower levels in the other gastric carcinomas and absence from the cell lines are surprising. Also upregulated in the tumours were thymosin beta 10 and prothymosin alpha. Thymosins are small proteins that were originally isolated from the thymus (Huff et al., 2001 ). Prothymosin alpha is now thought to play a role in cell proliferation, and its upregulation in gastric cancer has been previously reported (Mitani et al., 2000) . Beta thymosins bind monomeric (globular) actin and thymosin beta 10 is known to be overexpressed in carcinomas compared with normal tissues, although the stomach has not previously been studied (Huff et al., 2001) . Thymosins represent interesting candidate targets, against which drugs are already in development (Huff et al., 2001) . The well-recognized phenomenon of tumour heterogeneity thus leads to far more variable levels of expression between samples for tumour-associated genes than for those transcripts more abundant in normal tissue.
Other genes upregulated in the tumours also have well-recognized roles in carcinogenesis, including growth factors (hepatocyte growth factor); their ligands (fibroblast growth factor receptor); and signal transducers including guanylate kinase and putative serine/ threonine protein kinases. The last are interesting since they and the related tyrosine kinases are often overexpressed in cancers, may be relatively tissue-specific, and have proven to make excellent therapeutic targets, for drugs such as Glivec (STI571) (Blume-Jensen and Hunter, 2001) . Genes involved in invasion and metastasis, such as collagenase I, were similarly overexpressed. Our gene expression profiles are consistent with the general cancer literature (Hanahan and Weinberg, 2000) , and with the cDNA array studies of gastric tumours, in which upregulated transcripts include growth factors and genes involved in the cell cycle, adhesion and invasion (El-Rifai et al., 2001; Hippo et al., 2002; Mori et al., 2002) . This supports the existence of common molecular targets in cancers for diagnosis and therapy.
Unlike other widely expressed genes, most cytoskeletal proteins were highly expressed in normal stomach and downregulated in the tumours, including keratin 8, an intermediate filament specific to simple glandular epithelia; desmoplakin, a major component of the desmosome, the intercellular junction; and alpha actinin, profilin, cofilin and gelsolin, which contribute to the actin microfilament cytoskeleton (Janke et al., 2000) . This altered expression pattern is shared with other carcinomas, and indeed functional assays suggest that many cytoskeletal proteins act as tumour suppressor genes (Janke et al., 2000) .
Most genes that were more highly expressed in normal stomach play a role in gastric function, and many were also gastric-specific. The stomach acts as a reservoir for food and mechanically churns and mixes it with gastric juice containing hydrochloric acid which is a sterilizing agent, denatures proteins and activates digestive enzymes, the protease pepsin, intrinsic factor, and gastric lipase (Owen, 1986) . There is early absorption of water, ions, short-chain fatty acids and alcohol. The mucosal lining must be protected from proteolytic and acid attack, and the activity of the stomach must be coordinated with the rest of the gut through neurohormonal mechanisms. One such gut hormone is gastrin, which we found to be gastric-specific and present only in normal antral mucosa (Figures 1 and 2 ). This is as expected: gastrin is secreted by antral G cells in response to food entering the stomach and stimulates the gastric body mucosa to secrete acid and pepsinogens (Owen, 1986) ; the latter were also gastric-specific. Gastrin is only occasionally identifiable in gastric adenocarcinomas although it is a major product of gastric carcinoid (neuroendocrine) tumours (Berner and Nesland, 1991) .
Defence against microorganisms is an important role of the gut (Owen, 1986) . Immunoglobulins, especially IgA splice variants, and the antibacterial proteins lysozyme and lipocalin 2 were abundant in normal stomach (the SAGE sample had a chronic gastritis) and were mostly downregulated in the tumours, and gastricspecific. IgA and lysozyme are well-characterized and known to be highly expressed in gastritis and in carcinomas of intestinal type, especially when well differentiated as in tumour 1 (Isaacson, 1982) . Lipocalins bind small lipophilic molecules, including bacterialderived lipopolysaccharides; lipocalin 2 has been reported in normal glandular epithelia but not, until now, in cancers (Friedl et al., 1999) .
The mucin MUC5 and trefoil factors pS2 and human spasmolytic polypeptide were similarly highly expressed in normal stomach, downregulated in the tumours, especially in the less well-differentiated Tumour 2, and gastric-specific. However, although pS2 emerges as specific to stomach compared with other normal tissues, it is also overexpressed in breast and other adenocarcinomas (Wong et al., 1999) . Mucins are high molecular weight glycoproteins, and trefoil factors (TFFs) are small peptides resistant to acid, enzymes and heat (Wong et al., 1999; Machado et al., 2000) . Both are normally coexpressed in a site-specific manner in glandular epithelia (Figure 2 ), where they act synergistically to protect and repair the mucosal surface. In a previous study, 60% of 96 gastric carcinomas expressed pS2 and MUC5, but only 10% contained spasmolytic polypeptide (Machado et al., 2000) , in keeping with our findings. Moreover, in a gene knockout model, mice lacking pS2 developed hyperplasia, dysplasia and carcinoma of the stomach, which suggests that pS2 may act as a gastric-specific tumour suppressor gene (Lefebvre et al., 1996) . It is possible that some of the less well-characterized genes identified in this study may play a similar role.
PSCA was expressed in normal stomach and downregulated in gastric carcinomas. This agrees with a recent paper characterizing PSCA, which was first identified through its overexpression in prostate cancer (Bahrenberg et al., 2000) . (PSCA is different from prostate-specific antigen (PSA)). Its function is unknown, but a role in cell adhesion has been proposed (Bahrenberg et al., 2000) .
Another major function of the gut is fluid and ion transport. Aquaporin 5 was more highly expressed in normal antrum and Tumour 1; it has not previously been identified in the stomach but is found in the salivary glands, and is one of a family of integral membrane proteins which act as water channels (Ma and Verkman, 1999) . Proteolipid protein 2 (colonic epithelium-enriched A4 protein) had a similar gastric expression pattern; it shows features of an ion channel (Breitwieser et al., 1997) , and although not previously described in the stomach or in humans, proteolipid protein 2 is abundant in gastric EST libraries in Unigene (Wheeler et al., 2001) .
Most transcripts more highly expressed in normal stomach (Table 2) were thus involved in gastric function. In some cases, the genes were well characterized, and for others their role could be inferred from the existing data on gastrointestinal physiology. However, we also identified known genes with unexpected expression patterns, as well as many new genes. For example, one tag was abundant in normal stomach, absent from the tumours, and gastric-specific, yet initially it matched only ESTs. These were used to create a cDNA probe for Northern blotting which confirmed the SAGE results. Simultaneously, the gene was identified by differential display by a Japanese group who designated it CA11 and reported the same expression pattern (Yoshikawa et al., 2000) . CA11 is one of the most common transcripts in normal stomach, which suggests that it is functionally important, and demonstrates the power of mRNA profiling in the identification of novel genes.
One gene that was expressed in the gastric carcinomas, and absent from normal stomach, was thought until recently to be specific to ovarian and mesothelial tissues. Mesothelin is a glycoprotein which may function in cell adhesion (Chang and Pastan, 1996) . It is present in normal mesothelium and malignant mesothelioma (Chang and Pastan, 1996) , and is also highly expressed in ovarian carcinomas compared with nontransformed ovarian epithelium and with other adenocarcinomas (Hough et al., 2000; Scheurle et al., 2000) . Mesothelin has thus been proposed as an ovarian/mesothelialspecific marker, but this is contradicted by our study and others: mesothelin has recently been identified in gastric cancer tissues and cell lines (El-Rifai et al., 2001; Hippo et al., 2001) ; in the latter, its expression is associated with peritoneal metastasis (Hippo et al., 2001) . This is not surprising given mesothelin's normal location, and renders it a candidate therapeutic target.
Some genes expressed in the gastric carcinomas and absent from normal stomach reflected the histological 'intestinal' tumour phenotype (Laure´n, 1965) . This expression pattern was shown by intestinal TFF, the third TFF, which is normally found in the small intestine and colon (Wong et al., 1999) ; sulphotransferase 1A1, which detoxifies xenobiotics and endogenous compounds (Harris et al., 2000) ; and butyrate response factor 2, which is normally found in the colon where the short-chain fatty acid butyrate is produced by bacterial 
The gastric tumours are described in detail in Table 4 . All four cell lines are derived from adenocarcinomas. b The + and À symbols are used to indicate the intensity of the staining, where À means no staining, +/À means focal weak staining and +++ means the strongest positive staining. Figure 2 shows immunohistochemical staining in the tissues used for SAGE.
c Spasm polypep indicates human spasmolytic polypeptide (TFF2) fermentation and acts as the main mucosal energy source (Gibson et al., 1999) . Once again, the molecular pathology and morphology of the tumours correlate. Some transcripts that were highly expressed in normal gastric antral mucosa, downregulated in gastric carcinoma, and tissue-specific by comparison with other normal glandular epithelia, turned out to be abundant also in pancreatic adenocarcinoma. Spasmolytic polypeptide, lipocalin 2 and PSCA were highlighted in a recent SAGE study as being upregulated in pancreatic adenocarcinoma by comparison with normal pancreatic ductal cells (Argani et al., 2001) , an expression pattern shared with MUC5 and MUC1 (Scheurle et al., 2000) , such that in both papers these genes were proposed as new markers of pancreatic cancer. In fact, pancreatic carcinomas often exhibit a gastric phenotype (Sessa et al., 1990) . The mechanisms underlying such metaplasias are unknown but may involve aberrant expression of the developmental homeobox genes (Beck et al., 2000) . In any case, these phenomena emphasize the need to examine a range of tissues when evaluating potential markers, preferably including techniques which enable target localization.
In conclusion, these are the first global profiles of gene expression created, using SAGE, for the stomach. The molecular pathology correlated with the morphology. The profiles of gastric carcinoma resembled those of other tumours, which supports the existence of common cancer-associated molecular targets. Gene expression in normal stomach differed from other normal glandular tissues but agreed with existing literature. Many novel transcripts have been identified. These molecular portraits increase our knowledge about the genes involved in normal gastric function and in malignant change in the stomach, and provide a catalogue of candidates from which to develop markers for better diagnosis and therapy of gastric carcinoma.
Materials and methods
Primary tissues and cell lines
Primary tissues were dissected by a histopathologist (KAO) from resection specimens, in accordance with contemporary ethical practice, then samples were frozen for later RNA extraction or fixed and processed for diagnostic histopathology. Primary tumours and normal mucosa were collected from oesophagus, stomach and colon: the gastric adenocarcinomas are detailed in Table 4 . Gastric and oesophageal cancer cell lines (AGS, KATO-III and OE19 from European Collection of Cell Cultures, Wiltshire, UK; MKN-45 from Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany) were grown according to the instructions provided.
RNA isolation and SAGE
Total RNA was isolated using TRIzol Reagent (Invitrogen, Paisley, UK). For SAGE, mRNA was purified using the Poly(A)Pure kit (Ambion Inc, TX, USA). The SAGE samples were two gastric adenocarcinomas, both distal and intestinal but from different patients; and normal gastric antral mucosa from a patient without gastric cancer. SAGE was performed as described previously (Velculescu et al., 1995; Zhang et al., 1997) . Tag sequences were analysed, using SAGE software (version 304) and Genbank databases, to produce a catalogue of expressed genes (the SAGE protocol and software may be obtained via http://www.sagenet.org/sage_protocol.htm). Tags and matching transcripts were further investigated using the National Center for Biotechnology Information (NCBI)'s online bioinformatics tools, SAGEmap and Unigene (http:// www.ncbi.nlm.nih.gov/SAGE/ and http://www.ncbi.nlm.nih.-gov/UniGene/index.html) Wheeler et al., 2001) .
To identify differentially expressed genes, the normal and tumour gastric libraries were compared using SAGE software and Microsoft t Access and Excel programs. Various definitions of differential expression have been used in previous SAGE studies, including: threefold, fivefold or 10-fold differences in tag ratio; P-values below 0.05, 0.01 or 0.001; and combinations thereof (Velculescu et al., 1995; Zhang et al., 1997; Hibi et al., 1998; Lal et al., 1999; Nacht et al., 1999; Velculescu et al., 1999; Hough et al., 2000; Waghray et al., 2001) . Our relatively stringent definition was a difference of fivefold or more combined with a P-value of 0.01 or less.
Genes expressed specifically in the stomach were identified by digital comparison with other glandular epithelia and mesothelium. One normal and one tumour SAGE library from each of breast, colon, ovary, pancreas, prostate and mesothelium were downloaded from the SAGEmap web-site (details available on request) . Normal stomach was compared pairwise with the normal libraries, and the pooled gastric carcinomas were compared with the tumours. Genes that appeared to be expressed specifically in the stomach on the basis of these six comparisons were then checked on-line against the many other normal and tumour libraries in SAGEmap Wheeler et al., 2001) . Here T and N refer to classical tumour staging (local tumour spread and presence of lymph node metastases) (Fuchs and Mayer, 1995) , but throughout the rest of the paper, T and N indicate the SAGE tumour and normal samples
Validation by Northern blotting and immunohistochemistry (IHC)
To validate the SAGE profiles, selected transcripts were studied in a wider gastrointestinal panel of 16 normal and tumour tissues and three cell lines (detailed in Figure 2 and Table 4 ). Where the expression of the gene in the gut was previously minimally investigated, Northern blotting was used. For better characterized genes, where antibodies were available, IHC was used. Multiple Northern blots were produced using the NorthernMax kit (Ambion Inc), identically loaded with 30 mg total RNA per lane. cDNA probes were generated from total RNA by reverse transcription-polymerase chain reaction (primer sequences available on request). The probe was labelled with [a- 32 P]dATP (Amersham Ltd, Buckinghamshire, UK) using the Strip-EZ PCR kit (Ambion Inc) then hybridized and washed according to the manufacturer's instructions.
IHC was performed on tissue processed for diagnostic histopathology. Cultured cells were pelleted in soft agar, and then similarly formalin-fixed and paraffin-embedded. Sections were stained using primary antibodies (pS2, MUC5AC from Lab Vision UK Ltd, Suffolk, UK; human spasmolytic polypeptide from Novocastra Laboratories Ltd, Newcastle upon Tyne, UK; gastrin, lysozyme and cytokeratin 8 from Dako Ltd, Cambridge, UK) and then the VECTASTAIN Universal Elite ABC-Peroxidase Kit (Vector Laboratories Ltd, Peterborough, UK) according to the manufacturers' instructions.
